These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 6151825)
1. [Computerized analysis of cardiovascular activity in the conscious unrestrained rat. Application to the study of a new antihypertensive agent]. Cerutti C; Su DF; Barrès C; Paultre CZ; Sassard J Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1167-71. PubMed ID: 6151825 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of S 9490-3, a new converting enzyme inhibitor: a computerized study in conscious spontaneously hypertensive rats. Barrès C; Cerutti C; Devissaguet M; Paultre C; Sassard J J Hypertens Suppl; 1985 Dec; 3(3):S207-9. PubMed ID: 2856704 [TBL] [Abstract][Full Text] [Related]
3. Effects of ketanserin on blood pressure variability in conscious spontaneously hypertensive rats. Cheng Y; Kong XB; Su DF Zhongguo Yao Li Xue Bao; 1992 May; 13(3):235-8. PubMed ID: 1442106 [TBL] [Abstract][Full Text] [Related]
4. Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats. Su DF; Xu LP; Miao CY; Xie HH; Shen FM; Jiang YY Acta Pharmacol Sin; 2004 Feb; 25(2):148-51. PubMed ID: 14769201 [TBL] [Abstract][Full Text] [Related]
5. Effects of music composed by Mozart and Ligeti on blood pressure and heart rate circadian rhythms in normotensive and hypertensive rats. Lemmer B Chronobiol Int; 2008 Nov; 25(6):971-86. PubMed ID: 19005899 [TBL] [Abstract][Full Text] [Related]
6. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat. Dowell RT; Houdi AA Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476 [TBL] [Abstract][Full Text] [Related]
7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
8. Effects of ACE inhibition and beta-blockade on plasminogen activator inhibitor-1 and transforming growth factor-beta1 in carotid glomus and autonomic ganglia in hypertensive rats. Toblli JE; Grana D; Cao G; Milei J Am J Hypertens; 2007 Mar; 20(3):326-34. PubMed ID: 17324747 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent. Prichard BN; Owens CW; Graham BR J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs. Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303 [TBL] [Abstract][Full Text] [Related]
11. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. Safar ME; Blacher J; Protogerou A; Achimastos A J Hypertens; 2008 Jan; 26(1):130-7. PubMed ID: 18090550 [TBL] [Abstract][Full Text] [Related]
12. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff. Epstein BJ; Anderson S Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086 [TBL] [Abstract][Full Text] [Related]
13. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
14. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768 [TBL] [Abstract][Full Text] [Related]
15. Sympathetic, parasympathetic and non-autonomic contributions to cardiovascular spectral powers in unanesthetized spontaneously hypertensive rats. Daffonchio A; Franzelli C; Di Rienzo M; Castiglioni P; Mancia G; Ferrari AU J Hypertens; 1995 Dec; 13(12 Pt 2):1636-42. PubMed ID: 8903624 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure and alpha-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca. Civantos B; Aleixandre A Eur J Pharmacol; 2004 Apr; 489(1-2):101-10. PubMed ID: 15063161 [TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats. Toblli JE; Cao G; Casas G; Mazza ON Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767 [TBL] [Abstract][Full Text] [Related]
18. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model]. Ponchon P; Elghozi JL Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874 [TBL] [Abstract][Full Text] [Related]
19. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
20. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study]. von Fallois J; Faülhaber HD Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]